Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

An update from Piramal Pharma Limited ( ($IN:PPLPHARMA) ) is now available. Piramal Pharma Limited announced the completion of a significant ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Santini, Board Member at Collegium Pharmaceutical, a company in the Health Care sector, just ...

Rogers, based on the FDA’s Orange Book, and the National Drug Code (NDC) database, it’s evident that supplier prior ...